Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New trial of Genasense plus Gleevec in Gleevec-resistant CML patients

Oct. 3, 2002

Optimer acquires license to Globo H vaccine

Oct. 3, 2002

Early phase III enrollment for extended-release Eligard

Oct. 3, 2002

Integrin antagonists covered by 3-Dimensional patent

Oct. 3, 2002

New metal complexes as prodrugs of antitumor compounds

Oct. 3, 2002

Geron receives award for ongoing development of telomerase inhibitors for cancer

Oct. 3, 2002

Benefit:risk ratio of tamoxifen for breast cancer prophylaxis evaluated in large trial

Oct. 3, 2002

Iseganan fails to meet primary endpoint in ulcerative oral mucositis phase III trial

Oct. 2, 2002

Orphan drug grant for Endostatin trial

Oct. 2, 2002

Idec gains license to develop HMN-214

Oct. 2, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...